Company: ANIX
Filing Date: 2025-03-11
Form Type: 10-Q
Source: 0001493152-25-009854
Chunk: 9

Company: Anixa Biosciences Inc
Filing Date: 2025-03-11
Form: 10-Q
Item: Part I, Item 8
Chunk 9
---
 respectively.

     9 

Stock Option Activity

During the three months ended
January 31, 2025 and 2024, we granted options to purchase 1,355,000 shares and 1,335,000 shares of common stock, respectively, to employees
and consultants, with exercise prices ranging from $2.37 to $4.39 per share, pursuant to the 2018 Share Plan. During the three months
ended January 31, 2025, no stock options were exercised. During the three months ended January 31, 2024, stock options to purchase 24,000
shares of common stock were exercised on a cash basis, with aggregate proceeds of approximately $67,000.

Stock Option Plans

During the three months ended
January 31, 2025, we had two stock option plans: the Anixa Biosciences, Inc. 2010 Share Incentive Plan (the “2010 Share Plan”)
and the Anixa Biosciences, Inc. 2018 Share Incentive Plan (the “2018 Share Plan”), which were adopted by our Board of Directors
on July 14, 2010 and January 25, 2018, respectively. The 2018 Share Plan was approved by our shareholders on March 29, 2018.

2010 Share Plan

The 2010 Share Plan provided for
the grant of nonqualified stock options, stock appreciation rights, stock awards, performance awards and stock units to employees, directors
and consultants. In accordance with the provisions of the 2010 Share Plan, the plan terminated with respect to the ability to grant future
awards on July 14, 2020. Information regarding the 2010 Share Plan for the three months ended January 31, 2025 is as follows:

 SCHEDULE OF OPTION ACTIVITY

    Shares  
    Weighted  Average Exercise  Price Per Share  
    Aggregate  Intrinsic Value  (in thousands) 
  
    Options outstanding at October 31, 2024 
     986,968  
    $2.77  

    Options outstanding and exercisable at January 31, 2025 
     986,968  
    $2.77  
    $566 

The following table summarizes
information about stock options outstanding and exercisable under the 2010 Share Plan as of January 31, 2025:

 SCHEDULE
OF OPTIONS OUTST